Larvol Delta - Phase-3-Clinical-Trial-of-Wujia-Yizhi-Granules-in-the-Treatment-of-Mildtomoderate-Alzheimer39s-Dementia-Syndrome-of-Deficiency-of-Spleen-and-Kidney

wujia yizhi granules (KH110) - Chengdu Kanghong Pharma

http://clinicaltrials.gov/ct2/show/NCT06534723

Oct 15, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next